Federal contractor profile
ADVANCED CELL DIAGNOSTICS, INC.
UEI UD6XW8DAGLK6CAGE 4FBA8Company website ↗
Active
Overview
- Legal name
- ADVANCED CELL DIAGNOSTICS, INC.
- Also known as
- ADVANCED CELL DIAGNOSTICS INC
- Registered location
- NEWARK, CA, USA
- Website
- Company website ↗
- Primary NAICS
- 541714 — Research and Development in Biotechnology (except Nanobiotechnology)
- Latest award activity
- Aug 14, 2026
Read company summary
ADVANCED CELL DIAGNOSTICS, INC. is associated with UEI UD6XW8DAGLK6 and CAGE 4FBA8 in public federal records. AcornBids currently links 15 prime awards totaling $637.8K in obligations to this entity. Its largest recorded federal customer by obligations is Department of Health and Human Services. Its recorded federal awards include work classified as Analytical Laboratory Instrument Manufacturing; Research and Development in Biotechnology (except Nanobiotechnology); In-Vitro Diagnostic Substance Manufacturing. These categories describe the loaded award records, not a complete list of company capabilities. Its primary SAM.gov NAICS is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)). Its public SAM.gov registration lists NEWARK, CA, USA.
At a glance
Lifetime prime obligations$637.8K
Prime awards15
Awards with future end dates3
Top-agency concentration96.1%
Prime contract obligations across loaded award records. Obligations are not revenue or contract ceilings. Summary updated Sep 28, 2026. Refresh pending; these totals may be out of date.
Business information
Public SAM.gov registration details.
- Legal name
- ADVANCED CELL DIAGNOSTICS, INC.
- Doing business as
- ADVANCED CELL DIAGNOSTICS INC
- UEI
- UD6XW8DAGLK6
- CAGE
- 4FBA8
- Registered address
- 7707 GATEWAY BLVD, NEWARK, CA, 94560, USA
- Registration status
- Active
- Primary NAICS
- 541714 — Research and Development in Biotechnology (except Nanobiotechnology)
- SAM activation
- Jan 14, 2026
- Initial registration
- Jun 7, 2006
- Entity start
- Apr 25, 2008
- SAM updated
- Jan 14, 2026
- Registration expires
- Jan 12, 2027
- Fiscal year end
- Jun 30
- Place of incorporation
- DE, USA
Federal award analysis
Net transaction obligations by federal fiscal period.
Transaction history is not available in the loaded data. Annual funding is not estimated from current award totals.
Recent federal awards
Prime contract awards. Select an award to review its history and source evidence.
| Award / description | Awarding agency | Obligations | Start date | End date |
|---|---|---|---|---|
| HHSF223201610487PIN SITU RNA DETECTION REAGENTS | Department of Health and Human Services | $22.8K | Aug 24, 2016 | Feb 28, 2018 |
| 75N98026P01060NHLBI: SUPPLY: COMET PACKAGE: AUTOMATED SEQIF STAINER AND IMAGING SYSTEM FOR SPATIAL MULTIOMICS ANALYSIS | Department of Health and Human Services | $399.8K | Jul 20, 2026 | Jan 20, 2027 |
| 75N91021P00473BIOLOGICAL AND REAGENT MATERIAL | Department of Health and Human Services | $10.5K | May 19, 2021 | Nov 18, 2021 |
| 75N98C26P00011ACD REAGENT KITS AND PROBES - GENERIC ITEM. | Department of Health and Human Services | $25.0K | Jan 16, 2026 | Jan 15, 2027 |
| 36C24E21N0029RNA SCOPE KITS | Department of Veterans Affairs | $0 | Jan 22, 2021 | Sep 21, 2021 |
| 36C24125P0975RNA SCOPE | Department of Veterans Affairs | $24.8K | Sep 30, 2025 | Sep 29, 2026 |
| 75N92025P00273RNASCOPE IN-HOUSE ASSAY | Department of Health and Human Services | $26.9K | Jul 21, 2025 | Sep 25, 2025 |
| 75N98C25P00077REAGENTS FOR RNASCOPE EXPERIMENTS - 8 KITS. | Department of Health and Human Services | $11.2K | Jun 12, 2025 | Jun 11, 2026 |
| 75N93025P00790RNASCOPE PROBES AND DETECTION KITS FOR ONGOING RESEARCH WITHIN THE LABORATORY OF MALARIA AND VECTOR RESEARCH MOSQUITO IMMUNITY & VECTOR COMPETENCE SECTION | Department of Health and Human Services | $14.1K | Mar 30, 2025 | May 30, 2025 |
| 75N94025P00145NIAAA: SUPPLIES: RNASCOPE HIPLEX PROBES ASSAY KIT | Department of Health and Human Services | $10.1K | Mar 10, 2025 | Mar 31, 2025 |
Upcoming positioning windows
Modeled recompete windows are estimates, not announced solicitations or guarantees.
Registration, certifications & contacts
| Registration evidence | Date |
|---|---|
| SAM updated | Jan 14, 2026 |
| Source loaded | Sep 26, 2026 |
| Initial registration | Jun 7, 2006 |
| Entity start | Apr 25, 2008 |
| Industry | Reported size status |
|---|---|
| 325412 — Pharmaceutical Preparation Manufacturing | Not reported |
| 325413 — In-Vitro Diagnostic Substance Manufacturing | Not reported |
| 541714 — Research and Development in Biotechnology (except Nanobiotechnology) | Not reported |
| Contact | Role | Published contact methods | Evidence | Source date |
|---|---|---|---|---|
| MATT MCMANUS | Government business | Contact method not published | SAM registration | Not available |
| PAYAL SHAH | Electronic business | Contact method not published | SAM registration | Not available |
Registered industries
- 325412 — Pharmaceutical Preparation Manufacturing
- 325413 — In-Vitro Diagnostic Substance Manufacturing
- 541714 — Research and Development in Biotechnology (except Nanobiotechnology)
Registration classifications and published certificates do not by themselves establish eligibility for a particular solicitation. View SAM source
Related companies worth researching
Explore the customer, work and award-size evidence behind each match.
370 awards
340 awards
199 awards
119 awards
115 awards
105 awards
98 awards
92 awards
Data coverage and methodology
Sources: SAM.gov registration, USAspending awards and transactions, and linked supporting records. Prime contract obligations, IDV ceilings and assistance amounts are kept separate. Missing records are not zero activity. Company claims are labeled separately. Recompete signals are rule-based scores out of 100. Positioning windows are AcornBids estimates.
No official subaward rows are loaded, so Acorn does not claim known teaming relationships.
Recently viewed companies
Keep your research moving
Save this company, track changes, and evaluate upcoming work against your targets.
Save to my research Find my fit